Krystal Biotech, Inc.KRYSNASDAQ
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
16 analysts·Moderate coverage
100%
Rating Distribution
Strong Buy
00%
Buy
16100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 5% above analyst consensus — near fair value expected.

Bear Case
$216.00
-23%
Consensus
$269.25
-5%
Bull Case
$327.00
+16%
Price Range16 analysts
Low
Consensus
High
$216.00
$327.00
Current Target
Current Price
$282.27
Above Target
$13.02

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$7.72(7 analysts)
P/E41x
Current: 41.1x
Actual
Estimate
Range (Low–High)
Stock Alarm Pro
Forward Growth Estimates (YoY)
FY2027
Rev+29.61%
EPS+33.22%
FY2028
Rev+25.08%
EPS+24.54%
FY2029
Rev+23.96%
EPS+45.42%

Earnings Surprises

Beat rate:67%(8/12 quarters)
Avg surprise:+13.4%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 30, 2026Goldman Sachs
Krystal Biotech price target raised to $327 from $206 at Goldman Sachs
Target:$327.00
+17.1%from $279.34
Jan 9, 2026H.C. Wainwright
Krystal Biotech price target raised to $310 from $240 at H.C. Wainwright
Target:$310.00
+24.5%from $248.91
Oct 17, 2025Guggenheim
Krystal Biotech price target raised to $224 from $189 at Guggenheim
Target:$224.00
+18.9%from $188.33
Aug 22, 2025Chardan Capital
Krystal Biotech price target lowered to $216 from $219 at Chardan
Target:$216.00
+43.5%from $150.49
Sep 11, 2024Stifel Nicolaus
Krystal Biotech price target raised to $220 from $204 at Stifel
Target:$220.00
+18.9%from $185.00
Sep 2, 2024Bank of America Securities
Krystal Biotech price target raised to $205 from $195 at BofA
Target:$205.00
+5.1%from $195.12
Aug 12, 2024Evercore ISI
Krystal Biotech price target raised to $206 from $201 at Evercore ISI
Target:$206.00
+13.1%from $182.17
Apr 15, 2024Stifel Nicolaus
Krystal Biotech (KRYS) PT Raised to $204 at Stifel
Target:$204.00
+20.2%from $169.75
Nov 7, 2022Chardan Capital
Krystal Biotech price target raised to $133 from $130 at Chardan
Target:$133.00
+70.4%from $78.05
Aug 8, 2022Chardan Capital
Krystal Biotech price target lowered to $130 from $137 at Chardan
Target:$130.00
+57.8%from $82.40